Focused Shockwave Therapy for Neck and Shoulder Myofascial Pain

NCT ID
NCT07660523
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Cishan Hospital, Ministry of Health and Welfare
Conditions
Myofascial Pain Syndrome

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Effectiveness of Second-Generation Focused Extracorporeal Shockwave Therapy Combined With Ultrasonographic Assessment in Myofascial Pain Syndrome of the Neck and Shoulder: A Pilot Randomized Controlled Trial

Enrollment: 60 participants (Estimated).

What is being studied

  • Behavioral: Home-Based Neck Exercise Program
  • Device: Second-Generation Focused Extracorporeal Shockwave Therapy

Who may be eligible

Ages
20 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Adults older than 20 years. * Clinical diagnosis of nonspecific neck and shoulder pain primarily arising from muscles and soft tissues in the upper trapezius or levator scapulae region, as determined by a physical medicine and rehabilitation physician. * Neck and shoulder pain lasting for at least 3 months. * Neck Disability Index score greater than 5. * No use of analgesic medication or muscle relaxants within the previous month. * No injection therapy, physical therapy, or other treatment for neck and shoulder pain within the previous month. * Ability to understand the study procedures and provide written informed consent. Exclusion Criteria: * Neck or shoulder pain caused by a neurologic disorder, including cervical radiculopathy. * Clinical or imaging diagnosis of cervical degenerative joint disease. * History of a rheumatic disease, including rheumatoid arthritis or systemic lupus erythematosus. * History of head or neck trauma. * History of cervical spine surgery. * History of whiplash injury. * Pregnancy. * Current or previous malignancy considered clinically relevant to shockwave therapy. * Bleeding disorder. * Current use of anticoagulant medication, including warfarin. * Acute inflammation or infection at the treatment site. * Implanted cardiac pacemaker or implantable cardioverter-defibrillator. * Any other condition judged by the study physician to make participation or focused shockwave therapy inappropriate or unsafe.

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: Taiwan

Sample of listed locations

  • CiShan hospital, Ministry of Health and Welfare — Kaohsiung City, 80230, Taiwan — Recruiting

Study details

Start date
July 13, 2026
Primary completion date
April 30, 2027
Completion date
May 30, 2027
First posted
June 22, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07660523
Registry last updated
September 15, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07660523 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Neck Pain studies | Clinical trial FAQ